ArticleEsophagus : official journal of the Japan Esophageal Society2023

Timing of the infusion of nivolumab for patients with recurrent or metastatic squamous cell carcinoma of the esophagus influences its efficacy.

Motoo Nomura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.